In the past four decades, the lung cancer incidence increased initially and then gradually decreased. Surgical rate experienced a fluctuant reduction, while the chemotherapy rate was in upward trend. The 5-year relative survival rate increased with years, but was still low.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2019) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: